Biopharma success demands both tech and strategy. I deconstruct the industry’s core—from Unit Cost Modeling, Market Evaluation, CDMO to GTM Strategy. Through practical frameworks and real-world BD stories, quantify risks and identify high-value opportunities long before committing capital.
